INTRODUCTION

Percutaneous coronary intervention (PCI) with stent implantation constitutes the most
Electronic supplementary material The online version of this article (doi:10.1007/s40119-013-0023-2) contains supplementary material, which is available to authorized users. common form of coronary revascularization, improving quality of life and even clinical outcome in certain patient subsets [1, 2] . Advances in stent technology have improved PCI results; however, acute (stent thrombosis) and late (in-stent restenosis and thrombosis) complications still occur [3] [4] [5] . Quantitative angiography (QCA) demonstrated that the presence of stent underexpansion contributes to restenosis and stent thrombosis [6] . Furthermore, the use of intracoronary ultrasound (IVUS) enables a more precise assessment of stent expansion than QCA and identifies stent malapposition. Several IVUS studies have shown that the presence of insufficient stent expansion and malapposition remain strong predictors of stent thrombosis [7] [8] [9] [10] [11] ; however, this invasive imaging technique is poorly reimbursed in many regions, increases procedural complexity and cost and is associated with significant center-to-center variations [12, 13] . Indeed, the use of IVUS requires technical expertise to perform and interpret the results.
The StentBoost (Philips Medical Systems, Eindoven, The Netherlands) is a novel imaging technique that augments the fluoroscopic visualization of stents [14] . Through superimposing motion-corrected acquisition frames, a superb-quality image of an already deployed stent can be created.
The aim of this study is to evaluate the complementary value of using StentBoost to improve the assessment of stent dimensions in addition to standard QCA by comparing the correlation of stent diameter with the goldstandard measurements by IVUS.
METHODS
This prospective, single-center cohort study included patients with known obstructive coronary artery disease undergoing PCI. for QCA analysis were selected from fully opacified angiograms that provided optimal visualization of the lesion-treated segment with the least degree of foreshortening. Calibration was performed with the use of the contrast-filled guiding catheter as the reference. Post-PCI, minimal stent diameter and stent diameter at the proximal and distal edges of the stent were obtained.
Intravascular Ultrasound
After infusion of 200 lg of intracoronary nitroglycerin, IVUS was performed using a 2.9 French 40 MHz rotational catheter (Atlantis TM Pro; Boston Scientific, Natick, MA, USA) with an automated pullback at 0.5 mm/s. IVUS was performed after stent implantation or postdilation when necessary per study protocol.
Quantitative IVUS analysis was performed using a commercially available software package (Galaxy; Boston Scientific, Natick, MA, USA). Minimal stent area, minimal stent diameter as well as stent diameter for the proximal and distal edges were recorded. The percent area expansion was defined as the minimum stent area divided by the average of the proximal and distal reference areas. In addition, the presence of edge dissections or hematoma at the stent edges was also recorded.
StentBoost Analysis
StentBoost was performed using a flat-panel detector that was positioned to minimize stent foreshortening. With the guiding catheter in the field and the balloon markers located within the stented segment, roughly 40 frames of digital cine (3 s), were acquired without injection of contrast at 15 frames per second ( 
RESULTS
Baseline characteristics are detailed in Table 1 (Fig. 2) , respectively.
QCA and StentBoost Measurements
Quantitative angiography measurements were performed in all 38 patients after placement of 54 stents. The mean percent diameter stenosis by QCA before intervention was 73 ± 11%. The mean lesion length was 14 ± 5 mm and vessel size was 3.25 ± 0.50 mm. After stent delivery and/or post-dilation, the minimal stent diameter by QCA was 2.76 ± 0.53 mm (Table 2) and by StentBoost 2.74 ± 0.49 mm. Stent expansion was 90 ± 8% by QCA and 88 ± 8% by StentBoost.
IVUS Measurements
Intravascular ultrasound measurements were performed in all 54 stents. The minimal stent diameter was 3.10 ± 0.51 mm ( 
Comparison of Stent Expansion by QCA, StentBoost and IVUS
Correlation coefficients, r-value and associated p values for all comparisons are given in Table 3 . For minimal stent diameter assessment, IVUS, StentBoost and QCA had optimal correlation, whereas correlations were slightly weaker for stent diameters at both edges (Table 3) . [14] . In the aforementioned study, minimal stent diameter by IVUS strongly correlated with StentBoost (r = 0.75, P\0.0001), while a good correlation was found with QCA (r = 0.65, P\0.0001).
Despite the optimal correlation and agreement found in our study, the absolute differences in minimal stent diameter values were not negligible (0.38 ± 0.06 mm). IVUS allows circumferential luminal assessment, while StentBoost is only two dimensional. Possibly, the use of multiple orthogonal views may increase StentBoost accuracy, but it may increase X-ray exposure [22] . Contrary to IVUS, the use of StentBoost does not significantly prolong the procedure, since the insertion of an additional catheter is not needed and imaging acquisition is rather fast. Although StentBoost requires additional X-ray exposure, this increment is minimal with respect to standard PCI and is not likely to be clinically relevant.
In the present study, the limitations include the lack of stent area data collection by QCA or StentBoost and only diameters were compared. 
